RNU6-1299P

Across TCGA pan-cancer cohorts, RNU6-1299P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-1299P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1299P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1299P expression acts as an unfavorable survival marker.

KIRC, KICH, and LUAD are the cancer types where RNU6-1299P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.686	0.819	<.001	93	view →
KICH	DFS	Tertile	All	0.081	0.904	<.001	90	view →
LUAD	OS	Tertile	III,IV	0.140	0.670	<.001	75	view →
THCA	DFS	Tertile	III,IV	0.288	0.752	<.001	63	view →
UVM	DFS	Tertile	All	0.207	0.772	.001	54	view →
COAD	DFS	Tertile	All	0.586	0.789	.009	48	view →
SKCM	DFS	Tertile	II,III,IV	0.334	0.692	<.001	36	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	18	view →
TGCT	OS	Tertile	All	0.814	0.967	.020	18	view →
UCEC	DFS	Tertile	IV	0.206	0.704	.033	18	view →
ACC	DFS	Tertile	All	0.194	0.588	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-1299P–KIRC (OS)

Open the KIRC breakdown →